SACHDEV, P, REECE, Lindsey, THOMSON, M, NATARAJAN, A, COPELAND, Robert, WALES, J K and WRIGHT, N P (2017). Intragastric balloon as an adjunct to lifestyle programme in severely obese adolescents: Impact on biomedical outcomes, and skeletal health". International journal of obesity (2005), 42 (1), 115-118. [Article]
Documents
16769:477281
PDF
Reece-Intragastric balloon as an adjunct to lifestyle programme(VoR).pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Reece-Intragastric balloon as an adjunct to lifestyle programme(VoR).pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Download (247kB) | Preview
16769:247579
PDF
Reece-Intragastric balloon as an adjunct to lifestyle programme(AM).pdf - Accepted Version
Available under License Creative Commons Attribution No Derivatives.
Reece-Intragastric balloon as an adjunct to lifestyle programme(AM).pdf - Accepted Version
Available under License Creative Commons Attribution No Derivatives.
Download (1MB) | Preview
Abstract
Intragastric Balloons are a temporary, reversible, and safer option compared to bariatric surgery to promote significant weight loss leading to improved metabolic outcomes. However due to subsequent weight regain, alternative procedures are now preferred in adults. In adolescents, more amenable to lifestyle change, balloons may be an alternative to less reversible procedures. Our aim was to assess the tolerability and efficacy of the intragastric balloon in severely obese adolescents and the impact of associated weight loss on biomedical outcomes (glucose metabolism, blood pressure, lipid profiles) and bone density. A 2-year cohort study of 12 adolescents (BMI >3.5 s.d., Tanner stage >4) following 6 months intragastric balloon placement was carried out. Subjects underwent anthropometry, oral glucose tolerance test, and DEXA scans at 0, 6 and 24 months. Results showed clinically relevant improvements in blood pressure, insulin: glucose metabolism, liver function and sleep apnoea at 6 months. Changes were not sustained at 2 years though some parameters (Diastolic BP, HBA1c, insulin AUC) demonstrated longer-term improvement despite weight regain. Despite weight loss, bone mass accrual showed age appropriate increases. In conclusion, the intra-gastric balloon was safe, well tolerated and effective in supporting short-term weight loss and clinically relevant improvement in obesity related complications, which resolved in some individuals. Benefits were not sustained in the majority at 2 years.International Journal of Obesity accepted article preview online, 05 September 2017. doi:10.1038/ijo.2017.215.
More Information
Statistics
Downloads
Downloads per month over past year
Metrics
Altmetric Badge
Dimensions Badge
Share
Actions (login required)
View Item |